FDA offers one year grace period
The US Food and Drug Administration (FDA) has released draft guidelines offering a reprieve for manufacturers which have not integrated product identifier requirements by the November 26 serialisation deadline.
The police draft assets action will not be taken against manufacturers who do not affix or imprint a product identifier to each package of prescription drugs before November 26, 2018.
Based on IN-Pharma Technologist.
05.07.2017
